Epidemic Group Invests $34 Mln in Potential Vaccine Printer Tech Epidemic Group Invests $34 Mln in Potential Vaccine Printer Tech
A coalition seeking to get ahead of the next pandemic has agreed a $34 million deal with German biotech CureVac to develop vaccine"printing" technology that aims to rapidly produce shots against multiple diseases.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Public Health & Prevention News Source Type: news
More News: Biotechnology | Epidemics | Epidemiology | Germany Health | International Medicine & Public Health | Pandemics | Pathology | Vaccines